生物
微生物群
肠道菌群
肠道微生物群
药品
人体微生物群
失调
计算生物学
粪便细菌疗法
药物开发
转录组
生物标志物
个性化医疗
人类健康
药物代谢
基因组
微生物生态学
抗菌剂
微生物代谢
代谢组
生物技术
细胞代谢
精密医学
功效
微生物学
移植
免疫系统
生物信息学
菌群(微生物学)
生物转化
有机体
作者
Sakha Al-Btoosh,Ryan F. Donnelly,S. C. KELLY
出处
期刊:Gut microbes
[Landes Bioscience]
日期:2025-12-23
卷期号:18 (1): 2604867-2604867
被引量:24
标识
DOI:10.1080/19490976.2025.2604867
摘要
The human gut microbiome plays a critical role in modulating pharmacological and toxicological responses to medications. With a gene pool vastly exceeding that of the human host, the gut microbiome acts as a metabolically active organ capable of transforming, inactivating, or accumulating drugs. This review explores the bidirectional interplay between prescription medicines and the gut microbiome, encompassing three key mechanisms: direct biotransformation by microbial enzymes, indirect modulation of host metabolism and signaling pathways, and drug bioaccumulation within microbial cells. Particular attention is given to six major drug classes: immunotherapeutics, chemotherapeutics, antidepressants, statins, hypoglycemics, and antihypertensives. The ways in which individual microbial profiles can influence therapeutic outcomes are also reviewed. We examined how common non-antibiotic pharmaceuticals can significantly alter microbial diversity and promote antimicrobial resistance. Strategies to enhance drug efficacy through microbiome modulation, including probiotics, prebiotics, and fecal microbiota transplantation (FMT), are critically assessed. Experimental models ranging from in vitro batch and chemostat systems to animal and clinical studies are compared in terms of their utility for studying drug‒microbiome interactions. Finally, emerging evidence suggesting the gut microbiota composition may serve as a predictive biomarker for personalized medicine and therapeutic success is highlighted. Understanding and harnessing the complex interrelationships between medicines and microorganisms could offer novel avenues to optimize treatment outcomes and mitigate adverse drug effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI